Site name unknown, Tel Hashomer

Site:	Site name unknown, Tel Hashomer
Address:
City:	Tel Hashomer
State:
Zip:
Country:	Israel

Phase	Trial	Trial Status	Site Status [desc]	Drug	NCT#
2	Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor	Completed	Closed	Nilotinib	NCT00633295